Podcast Host Chris Leidli

Rx for Biotech

Business EN ↓ 97 episodes

"Rx for Biotech" is a healthcare education podcast dedicated to helping patients, caregivers, and healthcare professionals understand the rapidly evolving world of advanced therapies - and how patients can access them. From cell therapies and gene therapies to radiopharmaceuticals, immunotherapies, and next-generation treatments for cancer and autoimmune disease, this channel bridges the gap between breakthrough science and real-world patient care. Hosted by Chris Leidli, founder of Genoplex and longtime host of the Rx for Biotech podcast, each episode features conversations with:• Biotech and...

Be sure to visit the podcast's website and support the creator: soundcloud.com

Author

Podcast Host Chris Leidli

Category

Business

Podcast website

soundcloud.com

Latest episode

Nov 10, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 10M+ downloads · 4.7+ rating iOS soon

Episodes

How Ryght is Building a Generative AI Platform for BioPharma 18.03.2024

Our guest for this podcast episode is Simon Arkell, CEO of Ryght. Ryght is developing the next generation of safe and secure generative AI to empower Life Science companies to ingest real-time data and make actionable knowledge directly available to discovery, clinical, and commercial teams.

Revolutionizing Genetic Counseling: A Conversation with Igentify CEO, Doron Behar 14.03.2024

Our guest for this podcast episode is Doron Behar, MD, PhD, co-founder and CEO of Igentify, a digital health, artificial intelligence and genetic counseling company. In this episode, Dr. Behar shares how his company has developed a medical-grade tech platform that optimizes genomic workflows and produces AI-generated personalized genetic counseling for patients.

ASGCT Annual Meeting Preview 11.03.2024

This episode features a preview of the American Society of Gene and Cell Therapy Annual Meeting scientific symposium on the impact of Generative AI on cell and gene therapy (CGT); best practices and real-world applications for communicators. Dr. Rory Bricker-Anthony shares insight into what attendees can expect to learn from the May 2024 session, including current tools and applications for CGT co...

2024 Biopharma Investment Outlook with Chris Dokomajilar 12.02.2024

Our guest in this podcast episode is Chris Dokomajilar, Founder and CEO of DealForma. DealForma’s comprehensive life science database includes meticulously researched licensing deal financial comps, up-to-date profiles, and historic company and pipeline data. In this special spotlight episode, we take a deeper dive into the investment landscape for advanced therapies and also AI investment and par...

How one Survivor beat the odds against Mucosal Melanoma 11.01.2024

We often don’t get the chance to hear from survivors and patient advocates whose lives have been impacted by advanced medicines; so that makes this podcast episode special as we talk to Chris White, a cancer survivor who faced the unimaginable when diagnosed with Mucosal Melanoma in 2018—a rare and aggressive cancer which makes Chris's journey even more exceptional. Today, Chris is not just a surv...

Mark Carbone on How Respiratory Muscle Training can improve Cardiopulmonary Outcomes 04.01.2024

Our guest for this podcast episode is Mark Carbone, the CEO of PN Medical. PN Medical is a leader in respiratory care and research. The company created “The Breather”, the world’s first combined respiratory muscle training device to strengthen respiratory muscles to optimize blood flow, lung function and strengthen the cardiopulmonary system.

Episode 2: Future Advances in Cell Therapy Analytics 19.12.2023

In part 2 of this special round table podcast series, we discuss the future trends and advances in cell therapy manufacturing and the impact of AI on the evolving cell therapy analytics space.

Episode 1: Current Advancements in Cell Therapy Analytics 10.12.2023

In part 1 of this special round table podcast series, we discuss the current trends and advances in cell therapy manufacturing and the impact of evolving manufacturing processes on the analytics space.

Health Policy Update: IRA, 340b Drug Pricing and PBMs 11.10.2023

Our guest for this podcast episode is Laura Hobbs, Director of Healthcare Policy at the American Action Forum. In this episode, we discuss the Inflation Reduction Act impact on Pharma and Patient Access, along with 340b drug pricing and new PBM utilization controls. Learn more about the American Action Forum, and subscribe to their weekly newsletter here: https://www.americanactionforum.org/

Special Episode: ASGCT Policy Summit Highlights 24.09.2023

In this special episode, listen to Emily Walsh Martin, PhD, Principal at Tremont Therapeutics Consulting, as she shares some of the key highlights from the American Society of Gene and Cell Therapy’s Policy Summit that was held in Washington, DC, on September 18th and 19th, 2023. Check out the full program and register to view the on-demand content online at asgct.org/advocacy/policy-summit/agenda

The IRA 1-year Anniversary Episode: What Lies Ahead? 21.09.2023

The Inflation Reduction Act was signed into law in August 2022. In this podcast episode, we look into what lies ahead as the policy implementation begins. Our guest in this episode is Dr. Robert Popovian, a clinical pharmacist and health economist with deep expertise in health policy, drug pricing and affordability, access, and patient advocacy.

Developing Best-in-Class Radiopharmaceuticals for Cancer Patients 19.09.2023

Our guests for this podcast episode are the co-founders of Ratio Therapeutics, CEO Jack Hoppin, PhD, and Chief Scientific Officer, John Babich, PhD. Ratio Therapeutics's mission is to develop best-in-class radiopharmaceuticals for the treatment of cancers.

ASGCT Policy Summit Preview 10.09.2023

Listen to Francesca Cook, VP of Market Access at Regenexbio, as she provides an overview of the program and what to expect at the American Society of Gene and Cell Therapy’s upcoming Policy Summit being held in Washington, DC, on September 18th and 19th, 2023. Check out the full program and register online at https://asgct.org/advocacy/policy-summit/agenda

How ChromaCode is Accelerating Biomarker Testing to Improve Patient Outcomes 07.09.2023

In this podcast episode, our guest is Mark McDonough, CEO of ChromaCode. ChromaCode is an innovator in genomics with a multiplexing platform that is driving integration from laboratories to physicians to patients, connecting them to the right treatment through its proven HDPCR™ multiplexing platform. This adaptable technology expands the accessibility of diagnostic applications to patient communit...

How Medicenna is Developing "Superkines" as Novel Immunotherapies 31.08.2023

In this podcast episode, our guest is Dr. Fahar Merchant, President and CEO of Medicenna Therapeutics. Medicenna is a clinical stage immunotherapy company that engineers novel, powerful and proprietary interleukins leveraging their Superkine Platform to modulate, fine-tune or amplify the immune system to tackle the most challenging diseases, including a broad range of cancers.

How Virax Biolabs is Developing a Potentially Game-Changing Immunology Platform for T-Cell Testing 13.07.2023

In this podcast episode, Tomasz George, Chief Scientific Officer at Virax Biolabs, shares how the company's ViraxImmune™ technology platform will empower patients to take control of their health and make informed decisions on how to respond to current and future viral threats. The company hopes their ViraxImmune™ platform will shift the way individuals are able to manage aspects of their immune he...

Novel Immunotherapy approaches to engaging the Innate Immune System 06.07.2023

In this podcast episode, Dr. Michael Alonso, VP of Immunology and Pharmacology at Bolt Biotherapeutics, discusses how the company is developing cancer therapies that engage the innate immune system to generate robust anti-tumor responses.

Emerging Therapies for Rare Genetic Mitochondrial Diseases 21.06.2023

Reneo Pharmaceuticals is a clinical-stage pharmaceutical company focused on the development of therapies for patients with rare genetic diseases including mitochondrial diseases with significant unmet medical needs. In this podcast episode, we speak with Gregory Flesher, President and CEO of Reneo to learn more about mavodelpar, the company's lead asset, which is being developed in two rare diseas...

Harnessing the Cell Cycle to Treat Cancer and other Serious Diseases 13.06.2023

In this podcast episode, Cyclacel CEO and President, Spiro Rombotis, shares how the company, is exploiting deeper understanding of molecular oncology to develop novel precision medicines based on cell cycle, transcriptional regulation, and mitosis biology.

American Society of Gene and Cell Therapy Meeting Highlights 30.05.2023

Chris Leidli reviews scientific and clinical highlights from the American Society of Gene and Cell Therapy (ASGCT) 2023 Annual Meeting with guest, Benjamin McLeod, MBIOT.

Emerging PSMA Targeted Radioantibody Therapies for Prostate Cancer with CEO, Philip Kantoff, MD 09.05.2023

In this podcast episode, Dr. Philip Kantoff, the CEO, CMO, and Co-Founder of Convergent Therapeutics reviews the company's efforts to develop next-generation radiopharmaceuticals for the treatment of cancer.

Progress in Developing Fibroblast Cell Therapies with FibroBiologics CEO, Pete O'Heeron 02.05.2023

FibroBiologics is the leading biotech company focused on developing and commercializing fibroblast cell-based therapies for patients suffering from chronic diseases. In this podcast episode, the Founder and CEO, Pete O'Heeron discusses the promise of fibroblast cell therapy to treat diseases such as multiple sclerosis, degenerative disk disease and more.

Erandi De Silva, PhD on Building a Gene Therapy Pipeline and Culture 25.04.2023

In this podcast episode, Dr. Erandi De Silva discusses the hybrid approach to gene therapy development at Forge Biologics, Inc., an emerging leader in the contract development and manufacturing (CDMO) market for advanced regenerative medicine products. Dr. De Silva also discusses the unique approach to building a culture and diverse talent pool within the Columbus, Ohio biotech ecosystem.

Gene Therapy Landscape Trends: An Interview with Forge Biologics CEO, Tim Miller, PhD 18.04.2023

Forge Biologics is on a mission to enable access to life-changing gene therapies and help bring them from idea into reality. In this podcast episode, we learn about trends in the gene therapy landscape and contract manufacturing from Co-Founder and CEO, Timothy Miller, PhD.

AACR 2023 Preview 11.04.2023

This podcast episode previews the key precision medicine and cellular therapy data being showcased at this year's American Association of Cancer Research annual meeting.

Listen to the Rx for Biotech podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.